MediaTek Demos 5G-Advanced FWA Platform at Network X 2026
MediaTek T930 modem integrates 8Rx/3Tx, Edge AI and Wi-Fi 8, delivering more than 70% higher uplink throughput and more than 40% higher downlink
HSINCHU,

Enabling AI Applications with High Bidirectional Bandwidth and Ultra-Low Latency
AI, cloud gaming and real-time cloud services continue to raise network access requirements for Gigabit bandwidth and ultra-low latency. For telecom operators, further expanding FWA commercial deployment requires not only higher wireless access performance, but also increased capacity and service quality while keeping core network upgrade costs under control. MediaTek T930 moves more intelligence and performance optimization capabilities to the CPE edge, integrating AI-AQM, the world's first 8Rx 3CC, 3Tx 5L, HPUE PC1 33 dBm and Wi-Fi 8, enabling telecom operators to further enhance FWA service capabilities through CPE innovation.
Through 8Rx 3CC, T930 can improve network downlink throughput by more than 40% while extending network coverage. At the same time, the combination of HPUE PC1 and 3Tx 5L increases transmission power by 5 dB, improving network uplink throughput by more than 70%. The resulting increase in overall capacity can help reduce the cost to serve each household and improve network investment efficiency.
MediaTek AI-AQM (Active Queue Management) brings intelligent queue management to the CPE edge. It's validated AI-AQM technology can provide cloud gaming users with up to a 10x improvement in network latency, enabling operators to further improve user experience for latency-sensitive applications such as cloud gaming without requiring major changes to the core network.
Exhibition: MediaTek + Airoha @ Booth K35
Network X 2026:
View original content to download multimedia:https://www.prnewswire.com/news-releases/mediatek-demos-5g-advanced-fwa-platform-at-network-x-2026-302900726.html
SOURCE Airoha Technology
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scalefusion Introduces Veltar Vulnerability Management to Connect Vulnerability Detection and Remediation
- MUVON Therapeutics Reports Positive 12-Month Phase 2 Follow-up Data Confirming Durable Efficacy of its First-in-Class Muscle Regeneration Therapy in Stress Urinary Incontinence
- ITM and Lumara Bio to Announce New Data for ¹⁷⁷Lu-edotreotide (ITM-11) and Ga-DPI-4452 at EANM 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share